Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Low-dose aspirin reduces cardiovascular events

16.11.2006
Taking low-dose aspirin daily reduces the risk of heart attack and stroke, as well as the risk of dying, among patients who previously have had a heart attack or stroke but whose cardiovascular disease has stabilized, according to a new analysis by Duke University Medical Center cardiologists.

The study also found that taking low-dose aspirin daily increases a patient's risk of bleeding, but the researchers said the protective benefits of aspirin outweigh this side effect. A daily dose of aspirin is considered low if it is between 81 milligrams and 325 milligrams.

"Among patients with stable cardiovascular disease, we found that low-dose aspirin reduced incidence of heart attack, stroke and death," said cardiology fellow Jeffrey Berger, M.D., who presented the results of the study on Wednesday, Nov. 15, at the annual scientific sessions of the American Heart Association, in Chicago.

"We also saw an increased risk of bleeding among patients taking aspirin, but as in the decision-making process involving any therapy, there is always the weighing of benefits and risks," Berger added. "Since a great majority of patients can tolerate aspirin, the benefits appear to outweigh the risks. Aspirin is a drug that has been used for many years. It is well-understood, effective, inexpensive and widely available. In aspirin we have a proven life-saver."

The study was supported by Duke's Division of Cardiology.

Aspirin exerts its protective effect by preventing the clumping together of platelets circulating in the blood, according to the researchers. It is this anticlotting action that also causes unwanted bleeding.

In the Duke study, Berger and colleagues combined the data from six clinical trials that enrolled patients with stable cardiovascular disease or stable angina, or chest pain, and gave them low-dose aspirin. In total, the trials included 9,853 patients.

The researchers found that patients who took low-dose aspirin had a 26 percent reduction in the risk of a nonfatal heart attack, a 25 percent reduction in the risk of stroke and a 13 percent reduction in risk of death, compared with similar heart patients who did not take aspirin. Taken together, Berger said, patients on low-dose aspirin had a 21 percent reduction in risk of experiencing a major cardiovascular event, a measurement that is the combination of the rates of nonfatal heart attack and stroke and of cardiovascular death.

In terms of aspirin's effect in promoting bleeding, the study found that one patient out of 111 who received low-dose aspirin experienced a bleeding episode, Berger said.

Putting the results another way, Berger said, the results suggest that treating 83 patients will prevent one nonfatal heart attack, treating 40 patients will prevent one stroke, treating 30 patients will prevent one major cardiovascular event and treating 71 patients will prevent one death.

"When compared to other medications that have been proven effective in preventing cardiovascular events, aspirin comes off looking very good," Berger said.

For example, 91 patients would need to be treated with ACE inhibitors to prevent one death, compared with 71 patients for aspirin, he said. ACE inhibitors dilate blood vessels, making it easier for the heart to pump blood. Ninety-one patients would need to be treated with the inhibitors to prevent one heart attack, compared with 83 for aspirin, and 167 would need to be treated with the inhibitors to prevent one stroke, compared with 40 patients with aspirin.

"These comparisons show that a cheap and inexpensive medicine like aspirin is just as good, if not better, than other expensive medicines," Berger said.

Still, there is room for improvement in aspirin therapy, he said. In particular, he said, more study is needed to identify what dosage in the low-dose range -- from 81 milligrams to 325 milligrams a day -- will provide the best benefit-to-risk profile.

Richard Merritt | EurekAlert!
Further information:
http://www.mc.duke.edu

More articles from Health and Medicine:

nachricht New High-Performance Center Translational Medical Engineering
26.04.2017 | Fraunhofer ITEM

nachricht A promising target for kidney fibrosis
21.04.2017 | Brigham and Women's Hospital

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Making lightweight construction suitable for series production

More and more automobile companies are focusing on body parts made of carbon fiber reinforced plastics (CFRP). However, manufacturing and repair costs must be further reduced in order to make CFRP more economical in use. Together with the Volkswagen AG and five other partners in the project HolQueSt 3D, the Laser Zentrum Hannover e.V. (LZH) has developed laser processes for the automatic trimming, drilling and repair of three-dimensional components.

Automated manufacturing processes are the basis for ultimately establishing the series production of CFRP components. In the project HolQueSt 3D, the LZH has...

Im Focus: Wonder material? Novel nanotube structure strengthens thin films for flexible electronics

Reflecting the structure of composites found in nature and the ancient world, researchers at the University of Illinois at Urbana-Champaign have synthesized thin carbon nanotube (CNT) textiles that exhibit both high electrical conductivity and a level of toughness that is about fifty times higher than copper films, currently used in electronics.

"The structural robustness of thin metal films has significant importance for the reliable operation of smart skin and flexible electronics including...

Im Focus: Deep inside Galaxy M87

The nearby, giant radio galaxy M87 hosts a supermassive black hole (BH) and is well-known for its bright jet dominating the spectrum over ten orders of magnitude in frequency. Due to its proximity, jet prominence, and the large black hole mass, M87 is the best laboratory for investigating the formation, acceleration, and collimation of relativistic jets. A research team led by Silke Britzen from the Max Planck Institute for Radio Astronomy in Bonn, Germany, has found strong indication for turbulent processes connecting the accretion disk and the jet of that galaxy providing insights into the longstanding problem of the origin of astrophysical jets.

Supermassive black holes form some of the most enigmatic phenomena in astrophysics. Their enormous energy output is supposed to be generated by the...

Im Focus: A Quantum Low Pass for Photons

Physicists in Garching observe novel quantum effect that limits the number of emitted photons.

The probability to find a certain number of photons inside a laser pulse usually corresponds to a classical distribution of independent events, the so-called...

Im Focus: Microprocessors based on a layer of just three atoms

Microprocessors based on atomically thin materials hold the promise of the evolution of traditional processors as well as new applications in the field of flexible electronics. Now, a TU Wien research team led by Thomas Müller has made a breakthrough in this field as part of an ongoing research project.

Two-dimensional materials, or 2D materials for short, are extremely versatile, although – or often more precisely because – they are made up of just one or a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Expert meeting “Health Business Connect” will connect international medical technology companies

20.04.2017 | Event News

Wenn der Computer das Gehirn austrickst

18.04.2017 | Event News

7th International Conference on Crystalline Silicon Photovoltaics in Freiburg on April 3-5, 2017

03.04.2017 | Event News

 
Latest News

The TU Ilmenau develops tomorrow’s chip technology today

27.04.2017 | Information Technology

Scientist invents way to trigger artificial photosynthesis to clean air

26.04.2017 | Materials Sciences

Ammonium nitrogen input increases the synthesis of anticarcinogenic compounds in broccoli

26.04.2017 | Agricultural and Forestry Science

VideoLinks
B2B-VideoLinks
More VideoLinks >>>